Skip to main content
OpenTrials
Completed

NCT Number: NCT04805684

Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia

Lung ultrasonography (LUS) is also used in COVID 19 pneumonia for diagnostic and follow-up purposes.It has been demonstrated in different studies that it can be used for pathologies in pleural and lung tissue. LUS was applied by different researchers by dividing the lungs into 12 and 14 regions and the results were shared.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lung Ultrasound COVID-19 Coronaviridae Infections Coronavirus Infections Covid19 Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital

Bursa, Turkey (Türkiye)

About this study

In our study, we aimed to determine the correlation between lung findings of COVID 19 pneumonia and thoracic tomography with the results of LUS applied to different numbers (12 versus 14) of areas.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 and 85 years old
  • Hospitalized in intensive care unit
  • PCR (polymerase chain reaction) tested
  • Thoracic CT applied

Exclusion criteria

  • Previous lung operation
  • Thoracic wall disorder
  • Interstitial lung disease
  • Patients who did not consent to participate in the study

Treatment and study plan

LUS Twelve area

Device

Application of 12 areas (2 posterior, 2 lateral, and 2 anterior)lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)

LUS Fourteen area

Device

Application of 14 areas (3 posterior, 2 lateral, and 2 anterior) lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)

Primary outcomes

  1. Correlation between Thoracic CT imaging results and LUS results

    Time frame: 6 hours

    Lung ultrasonography will be performed within 6 hours of the Thoracic CT.

Secondary outcomes

  1. Characteristics of lesions

    Time frame: 6 hours

    Identifying the characteristics of the abnormal findings detected in Thoracic CT and LUS

Sponsors and collaborators

Lead sponsor

Bursa Yuksek Ihtisas Training and Research Hospital

Other Gov

Registry information

Official study title

Comparison of Two Different Lung Ultrasound Imaging Protocols in COVID -19 Pneumonia

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Mar 18, 2021
Registry last updated
Mar 18, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.